

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.53869024 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.53869024 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.02606248 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.02606248 |
| 5 | intestinal cholesterol absorption (GO:0030299) | 4.78095197 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 4.61833921 |
| 7 | protein carboxylation (GO:0018214) | 4.54508115 |
| 8 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.54508115 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.52362764 |
| 10 | negative regulation of fibrinolysis (GO:0051918) | 4.46077889 |
| 11 | COPII vesicle coating (GO:0048208) | 4.37184522 |
| 12 | regulation of protein activation cascade (GO:2000257) | 4.32062192 |
| 13 | bile acid biosynthetic process (GO:0006699) | 4.28344478 |
| 14 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.23224102 |
| 15 | regulation of RIG-I signaling pathway (GO:0039535) | 4.21944731 |
| 16 | regulation of fibrinolysis (GO:0051917) | 4.17772834 |
| 17 | urea metabolic process (GO:0019627) | 4.17253140 |
| 18 | urea cycle (GO:0000050) | 4.17253140 |
| 19 | Golgi transport vesicle coating (GO:0048200) | 4.13868689 |
| 20 | COPI coating of Golgi vesicle (GO:0048205) | 4.13868689 |
| 21 | glyoxylate metabolic process (GO:0046487) | 4.09209636 |
| 22 | regulation of complement activation (GO:0030449) | 4.05765956 |
| 23 | regulation of bile acid biosynthetic process (GO:0070857) | 4.05715914 |
| 24 | complement activation, alternative pathway (GO:0006957) | 3.97627339 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 3.96226885 |
| 26 | cellular glucuronidation (GO:0052695) | 3.95670895 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 3.94163013 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 3.93290623 |
| 29 | cysteine metabolic process (GO:0006534) | 3.90271254 |
| 30 | triglyceride homeostasis (GO:0070328) | 3.89433692 |
| 31 | acylglycerol homeostasis (GO:0055090) | 3.89433692 |
| 32 | tryptophan metabolic process (GO:0006568) | 3.85582776 |
| 33 | necroptotic process (GO:0070266) | 3.85079273 |
| 34 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.84947204 |
| 35 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.84947204 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 3.84038387 |
| 37 | NIK/NF-kappaB signaling (GO:0038061) | 3.78356970 |
| 38 | homocysteine metabolic process (GO:0050667) | 3.78148105 |
| 39 | alpha-linolenic acid metabolic process (GO:0036109) | 3.73362146 |
| 40 | bile acid metabolic process (GO:0008206) | 3.72663208 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 3.67466565 |
| 42 | indolalkylamine catabolic process (GO:0046218) | 3.64618857 |
| 43 | tryptophan catabolic process (GO:0006569) | 3.64618857 |
| 44 | indole-containing compound catabolic process (GO:0042436) | 3.64618857 |
| 45 | tyrosine metabolic process (GO:0006570) | 3.62933751 |
| 46 | bile acid and bile salt transport (GO:0015721) | 3.62125529 |
| 47 | intestinal absorption (GO:0050892) | 3.61903540 |
| 48 | nuclear pore complex assembly (GO:0051292) | 3.61696472 |
| 49 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.56980202 |
| 50 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.56931192 |
| 51 | protein retention in ER lumen (GO:0006621) | 3.51465660 |
| 52 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.50379657 |
| 53 | reverse cholesterol transport (GO:0043691) | 3.49026888 |
| 54 | ER overload response (GO:0006983) | 3.48823228 |
| 55 | cholesterol efflux (GO:0033344) | 3.41409802 |
| 56 | glucuronate metabolic process (GO:0019585) | 3.38768981 |
| 57 | uronic acid metabolic process (GO:0006063) | 3.38768981 |
| 58 | kynurenine metabolic process (GO:0070189) | 3.37215207 |
| 59 | plasma lipoprotein particle assembly (GO:0034377) | 3.33314602 |
| 60 | negative regulation of protein activation cascade (GO:2000258) | 3.32040691 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 3.28376758 |
| 62 | regulation of necroptotic process (GO:0060544) | 3.27692882 |
| 63 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.27548850 |
| 64 | lysine catabolic process (GO:0006554) | 3.27159703 |
| 65 | lysine metabolic process (GO:0006553) | 3.27159703 |
| 66 | aromatic amino acid family metabolic process (GO:0009072) | 3.26948937 |
| 67 | negative regulation of cholesterol transport (GO:0032375) | 3.25808871 |
| 68 | negative regulation of sterol transport (GO:0032372) | 3.25808871 |
| 69 | iron ion import (GO:0097286) | 3.23518800 |
| 70 | lipoprotein metabolic process (GO:0042157) | 3.23003668 |
| 71 | regulation of cholesterol homeostasis (GO:2000188) | 3.22858980 |
| 72 | protein-lipid complex remodeling (GO:0034368) | 3.21619889 |
| 73 | macromolecular complex remodeling (GO:0034367) | 3.21619889 |
| 74 | plasma lipoprotein particle remodeling (GO:0034369) | 3.21619889 |
| 75 | epoxygenase P450 pathway (GO:0019373) | 3.19150634 |
| 76 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 3.18998152 |
| 77 | phospholipid efflux (GO:0033700) | 3.17319674 |
| 78 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.16942830 |
| 79 | response to nitrosative stress (GO:0051409) | 3.16517202 |
| 80 | fibrinolysis (GO:0042730) | 3.15519414 |
| 81 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 3.13022076 |
| 82 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.12761526 |
| 83 | protein-lipid complex assembly (GO:0065005) | 3.11372015 |
| 84 | nuclear pore organization (GO:0006999) | 3.10850869 |
| 85 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.08289881 |
| 86 | cholesterol homeostasis (GO:0042632) | 3.02916323 |
| 87 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.00778671 |
| 88 | drug transmembrane transport (GO:0006855) | 3.00763956 |
| 89 | coenzyme catabolic process (GO:0009109) | 3.00262381 |
| 90 | necrotic cell death (GO:0070265) | 3.00118536 |
| 91 | serine family amino acid catabolic process (GO:0009071) | 3.00089302 |
| 92 | sterol homeostasis (GO:0055092) | 2.99087491 |
| 93 | regulation of protein polyubiquitination (GO:1902914) | 2.98158344 |
| 94 | negative regulation of lipase activity (GO:0060192) | 2.97663471 |
| 95 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.97112581 |
| 96 | programmed necrotic cell death (GO:0097300) | 2.96059375 |
| 97 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.95334338 |
| 98 | signal peptide processing (GO:0006465) | 2.93143781 |
| 99 | definitive hemopoiesis (GO:0060216) | 2.92524815 |
| 100 | hepatocyte apoptotic process (GO:0097284) | 2.91997556 |
| 101 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.91880253 |
| 102 | histone mRNA catabolic process (GO:0071044) | 2.87900442 |
| 103 | drug catabolic process (GO:0042737) | 2.87372624 |
| 104 | imidazole-containing compound metabolic process (GO:0052803) | 2.87299727 |
| 105 | indolalkylamine metabolic process (GO:0006586) | 2.86153064 |
| 106 | phospholipid homeostasis (GO:0055091) | 2.82991460 |
| 107 | sphingomyelin metabolic process (GO:0006684) | 2.81782118 |
| 108 | valine metabolic process (GO:0006573) | 2.81192390 |
| 109 | heme transport (GO:0015886) | 2.80551703 |
| 110 | alpha-amino acid catabolic process (GO:1901606) | 2.80464038 |
| 111 | ethanol oxidation (GO:0006069) | 2.78651435 |
| 112 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.78639665 |
| 113 | regulation of cholesterol esterification (GO:0010872) | 2.78497906 |
| 114 | arginine metabolic process (GO:0006525) | 2.77399714 |
| 115 | complement activation, classical pathway (GO:0006958) | 2.74356287 |
| 116 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.72711010 |
| 117 | cytolysis (GO:0019835) | 2.72187946 |
| 118 | drug metabolic process (GO:0017144) | 2.72089805 |
| 119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.71213344 |
| 120 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.71213344 |
| 121 | benzene-containing compound metabolic process (GO:0042537) | 2.70954640 |
| 122 | Rap protein signal transduction (GO:0032486) | 2.70775930 |
| 123 | mRNA modification (GO:0016556) | 2.70358661 |
| 124 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.70087811 |
| 125 | complement activation (GO:0006956) | 2.69934594 |
| 126 | amino-acid betaine metabolic process (GO:0006577) | 2.69926539 |
| 127 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.68890741 |
| 128 | ribosome assembly (GO:0042255) | 2.68787677 |
| 129 | pore complex assembly (GO:0046931) | 2.68516637 |
| 130 | hormone catabolic process (GO:0042447) | 2.68426931 |
| 131 | chondrocyte development (GO:0002063) | 2.68221172 |
| 132 | regulation of plasminogen activation (GO:0010755) | 2.66402029 |
| 133 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.65790623 |
| 134 | phagocytosis, engulfment (GO:0006911) | 2.65262180 |
| 135 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.64916244 |
| 136 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.64682315 |
| 137 | negative regulation of interleukin-17 production (GO:0032700) | 2.63563293 |
| 138 | positive regulation of protein autophosphorylation (GO:0031954) | 2.61416691 |
| 139 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.58993372 |
| 140 | negative regulation of necroptotic process (GO:0060546) | 2.57711771 |
| 141 | negative regulation of type 2 immune response (GO:0002829) | 2.54623633 |
| 142 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.52534083 |
| 143 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.52534083 |
| 144 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.52534083 |
| 145 | polyol biosynthetic process (GO:0046173) | 2.51776550 |
| 146 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.50873056 |
| 147 | detection of molecule of bacterial origin (GO:0032490) | 2.50101872 |
| 148 | histamine secretion (GO:0001821) | 2.46074763 |
| 149 | vesicle coating (GO:0006901) | 2.45831222 |
| 150 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.44025986 |
| 151 | neutrophil activation (GO:0042119) | 2.43591963 |
| 152 | regulation of sulfur metabolic process (GO:0042762) | 2.43585592 |
| 153 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.43385985 |
| 154 | organelle membrane fusion (GO:0090174) | 2.40252561 |
| 155 | regulation of coenzyme metabolic process (GO:0051196) | 2.39874467 |
| 156 | regulation of cofactor metabolic process (GO:0051193) | 2.39874467 |
| 157 | positive regulation of coagulation (GO:0050820) | 2.38737403 |
| 158 | peroxisome fission (GO:0016559) | 2.38186863 |
| 159 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.37649518 |
| 160 | membrane budding (GO:0006900) | 2.37454273 |
| 161 | proteasome assembly (GO:0043248) | 2.36508614 |
| 162 | ether lipid metabolic process (GO:0046485) | 2.35495736 |
| 163 | regulation of memory T cell differentiation (GO:0043380) | 2.35050834 |
| 164 | cellular extravasation (GO:0045123) | 2.34945466 |
| 165 | positive regulation of blood coagulation (GO:0030194) | 2.34363703 |
| 166 | positive regulation of hemostasis (GO:1900048) | 2.34363703 |
| 167 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.33878819 |
| 168 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.33666832 |
| 169 | mitotic sister chromatid cohesion (GO:0007064) | 2.33119501 |
| 170 | regulation of interleukin-17 production (GO:0032660) | 2.32612005 |
| 171 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.31964058 |
| 172 | cell adhesion mediated by integrin (GO:0033627) | 2.31432421 |
| 173 | germinal center formation (GO:0002467) | 2.30765091 |
| 174 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.28445218 |
| 175 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.27988741 |
| 176 | regulation of fibroblast apoptotic process (GO:2000269) | 2.27766245 |
| 177 | thrombin receptor signaling pathway (GO:0070493) | 2.27691004 |
| 178 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.26945946 |
| 179 | non-recombinational repair (GO:0000726) | 2.26945946 |
| 180 | hypotonic response (GO:0006971) | 2.25805584 |
| 181 | protein localization to Golgi apparatus (GO:0034067) | 2.24734130 |
| 182 | regulation of regulatory T cell differentiation (GO:0045589) | 2.24355310 |
| 183 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.23636899 |
| 184 | cellular response to glucose starvation (GO:0042149) | 2.22663969 |
| 185 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.22092864 |
| 186 | granulocyte activation (GO:0036230) | 2.21676783 |
| 187 | AMP metabolic process (GO:0046033) | 2.21128278 |
| 188 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.20929931 |
| 189 | mesodermal cell differentiation (GO:0048333) | 2.20813109 |
| 190 | regulation of DNA endoreduplication (GO:0032875) | 2.19318436 |
| 191 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.18991318 |
| 192 | regulation of transforming growth factor beta production (GO:0071634) | 2.18056494 |
| 193 | cellular response to ethanol (GO:0071361) | 2.16347418 |
| 194 | I-kappaB phosphorylation (GO:0007252) | 2.16201108 |
| 195 | neutrophil mediated immunity (GO:0002446) | 2.14462587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.98608096 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.07970045 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.09140411 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.80509915 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.49091522 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.39992772 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 3.93091206 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.43659261 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.37804095 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.07901404 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.83550877 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.77428826 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.61717036 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.52109409 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.43285325 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.32472900 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.99451652 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.90392381 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.88149956 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.84367075 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.80840464 |
| 22 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.79736248 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.78638785 |
| 24 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.70550837 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.69659751 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.68284598 |
| 27 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.65934087 |
| 28 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.64650494 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62837806 |
| 30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.59035020 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.57432720 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54905297 |
| 33 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51136015 |
| 34 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.50791815 |
| 35 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.50614195 |
| 36 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.49317211 |
| 37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.49317211 |
| 38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.48842177 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.48785872 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48680952 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.47082178 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.46073489 |
| 43 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.45330807 |
| 44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.44783324 |
| 45 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.43663587 |
| 46 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42868822 |
| 47 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42247605 |
| 48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.41173761 |
| 49 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.40535759 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40318385 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.35338390 |
| 52 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.34825710 |
| 53 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.33495441 |
| 54 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.32059629 |
| 55 | EWS_26573619_Chip-Seq_HEK293_Human | 1.29531374 |
| 56 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.29157501 |
| 57 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.29061121 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27464422 |
| 59 | MYB_26560356_Chip-Seq_TH2_Human | 1.25639040 |
| 60 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25596786 |
| 61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25018566 |
| 62 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24826610 |
| 63 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24771831 |
| 64 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.22213616 |
| 65 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22163925 |
| 66 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.21011292 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20350021 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20346301 |
| 69 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.20322009 |
| 70 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.20151156 |
| 71 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.19819658 |
| 72 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18052556 |
| 73 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.18042076 |
| 74 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.15909677 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.15392738 |
| 76 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.14940744 |
| 77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14582284 |
| 78 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.13833232 |
| 79 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.13080760 |
| 80 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.13080760 |
| 81 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.12663217 |
| 82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.11878119 |
| 83 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09493668 |
| 84 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08112422 |
| 85 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06112296 |
| 86 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05803748 |
| 87 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05291156 |
| 88 | MYB_26560356_Chip-Seq_TH1_Human | 1.05114585 |
| 89 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04679666 |
| 90 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.04358287 |
| 91 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.03728813 |
| 92 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03205168 |
| 93 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02985193 |
| 94 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.02558314 |
| 95 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01377015 |
| 96 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01097220 |
| 97 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.00951218 |
| 98 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.99057526 |
| 99 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99050448 |
| 100 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98915925 |
| 101 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.97781799 |
| 102 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96850082 |
| 103 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93801903 |
| 104 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93087027 |
| 105 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92998892 |
| 106 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92942769 |
| 107 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92028979 |
| 108 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.92024161 |
| 109 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90872915 |
| 110 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90108186 |
| 111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89324892 |
| 112 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89284654 |
| 113 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89016268 |
| 114 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.88841180 |
| 115 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.88744833 |
| 116 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88635078 |
| 117 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.88304195 |
| 118 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.88293856 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87655185 |
| 120 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.87427241 |
| 121 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87018503 |
| 122 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86867288 |
| 123 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.86280302 |
| 124 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.84810398 |
| 125 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.83627174 |
| 126 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83222382 |
| 127 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.82695830 |
| 128 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.81780080 |
| 129 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.80998237 |
| 130 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.79629593 |
| 131 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79486924 |
| 132 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.79252494 |
| 133 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.79068689 |
| 134 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.78679756 |
| 135 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.78535913 |
| 136 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78500017 |
| 137 | * SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.78106278 |
| 138 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.77747625 |
| 139 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.77054788 |
| 140 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.74089722 |
| 141 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.73566198 |
| 142 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.72813490 |
| 143 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72235211 |
| 144 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.72100867 |
| 145 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.71253961 |
| 146 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.71244091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.15840262 |
| 2 | MP0005360_urolithiasis | 5.42151807 |
| 3 | MP0005365_abnormal_bile_salt | 4.42261925 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.29001154 |
| 5 | MP0008057_abnormal_DNA_replication | 3.90594250 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.18286845 |
| 7 | MP0003252_abnormal_bile_duct | 3.01005416 |
| 8 | MP0001666_abnormal_nutrient_absorption | 2.90805974 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.77760027 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.28893849 |
| 11 | MP0009697_abnormal_copulation | 2.27085277 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.19315779 |
| 13 | MP0006054_spinal_hemorrhage | 2.15392897 |
| 14 | MP0002009_preneoplasia | 2.14756535 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.07374471 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.04145096 |
| 17 | MP0005220_abnormal_exocrine_pancreas | 1.99201436 |
| 18 | MP0003195_calcinosis | 1.98961385 |
| 19 | MP0002396_abnormal_hematopoietic_system | 1.98730950 |
| 20 | MP0003828_pulmonary_edema | 1.94312031 |
| 21 | MP0005408_hypopigmentation | 1.88846512 |
| 22 | MP0001835_abnormal_antigen_presentation | 1.88720668 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.88445292 |
| 24 | MP0008438_abnormal_cutaneous_collagen | 1.84844676 |
| 25 | MP0008004_abnormal_stomach_pH | 1.82625161 |
| 26 | MP0003868_abnormal_feces_composition | 1.78845464 |
| 27 | MP0005083_abnormal_biliary_tract | 1.75360563 |
| 28 | MP0000609_abnormal_liver_physiology | 1.74115246 |
| 29 | MP0010368_abnormal_lymphatic_system | 1.72550355 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.69027307 |
| 31 | MP0003221_abnormal_cardiomyocyte_apopto | 1.55924110 |
| 32 | MP0009384_cardiac_valve_regurgitation | 1.55405107 |
| 33 | MP0005332_abnormal_amino_acid | 1.50302145 |
| 34 | MP0003091_abnormal_cell_migration | 1.50296460 |
| 35 | MP0002006_tumorigenesis | 1.47703835 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.46871597 |
| 37 | MP0003303_peritoneal_inflammation | 1.44982199 |
| 38 | MP0004264_abnormal_extraembryonic_tissu | 1.43937313 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.41468274 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.41468274 |
| 41 | MP0004084_abnormal_cardiac_muscle | 1.39524864 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.36738847 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.35591688 |
| 44 | MP0003448_altered_tumor_morphology | 1.35081725 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.34719023 |
| 46 | MP0009840_abnormal_foam_cell | 1.29273491 |
| 47 | MP0002118_abnormal_lipid_homeostasis | 1.26665929 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.19650870 |
| 49 | MP0002332_abnormal_exercise_endurance | 1.19063269 |
| 50 | MP0008058_abnormal_DNA_repair | 1.17020212 |
| 51 | MP0004147_increased_porphyrin_level | 1.15804853 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.13822016 |
| 53 | MP0009053_abnormal_anal_canal | 1.13263204 |
| 54 | MP0001851_eye_inflammation | 1.11530108 |
| 55 | MP0005275_abnormal_skin_tensile | 1.11323992 |
| 56 | MP0005319_abnormal_enzyme/_coenzyme | 1.10696938 |
| 57 | MP0000598_abnormal_liver_morphology | 1.10333254 |
| 58 | MP0002060_abnormal_skin_morphology | 1.08728558 |
| 59 | MP0009785_altered_susceptibility_to | 1.07708707 |
| 60 | MP0004272_abnormal_basement_membrane | 1.07288670 |
| 61 | MP0000569_abnormal_digit_pigmentation | 1.07202371 |
| 62 | MP0005023_abnormal_wound_healing | 1.06406914 |
| 63 | MP0004019_abnormal_vitamin_homeostasis | 1.06232910 |
| 64 | MP0001853_heart_inflammation | 1.05862217 |
| 65 | MP0005000_abnormal_immune_tolerance | 1.05790418 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.05695770 |
| 67 | MP0002148_abnormal_hypersensitivity_rea | 1.05357103 |
| 68 | MP0004957_abnormal_blastocyst_morpholog | 1.04798192 |
| 69 | MP0002398_abnormal_bone_marrow | 1.04016558 |
| 70 | MP0004484_altered_response_of | 1.02166997 |
| 71 | MP0005084_abnormal_gallbladder_morpholo | 1.01773104 |
| 72 | MP0000516_abnormal_urinary_system | 1.01712460 |
| 73 | MP0005367_renal/urinary_system_phenotyp | 1.01712460 |
| 74 | MP0003724_increased_susceptibility_to | 1.00992462 |
| 75 | MP0002933_joint_inflammation | 0.98803699 |
| 76 | MP0001243_abnormal_dermal_layer | 0.97943109 |
| 77 | MP0009379_abnormal_foot_pigmentation | 0.97865260 |
| 78 | MP0005503_abnormal_tendon_morphology | 0.97611776 |
| 79 | MP0002419_abnormal_innate_immunity | 0.96871235 |
| 80 | MP0005076_abnormal_cell_differentiation | 0.93502955 |
| 81 | MP0005621_abnormal_cell_physiology | 0.93090726 |
| 82 | MP0000689_abnormal_spleen_morphology | 0.92933609 |
| 83 | MP0001879_abnormal_lymphatic_vessel | 0.92892831 |
| 84 | MP0004036_abnormal_muscle_relaxation | 0.91341744 |
| 85 | MP0002405_respiratory_system_inflammati | 0.91323264 |
| 86 | MP0002452_abnormal_antigen_presenting | 0.90969540 |
| 87 | MP0002722_abnormal_immune_system | 0.90890374 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 0.90758350 |
| 89 | MP0001800_abnormal_humoral_immune | 0.90401307 |
| 90 | MP0003786_premature_aging | 0.89641298 |
| 91 | MP0002723_abnormal_immune_serum | 0.86157413 |
| 92 | MP0002896_abnormal_bone_mineralization | 0.84585960 |
| 93 | MP0002928_abnormal_bile_duct | 0.84456759 |
| 94 | MP0001944_abnormal_pancreas_morphology | 0.84299712 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.84148041 |
| 96 | MP0005266_abnormal_metabolism | 0.82920637 |
| 97 | MP0000013_abnormal_adipose_tissue | 0.82776976 |
| 98 | MP0001730_embryonic_growth_arrest | 0.82717856 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.82618333 |
| 100 | MP0004215_abnormal_myocardial_fiber | 0.82609653 |
| 101 | MP0000465_gastrointestinal_hemorrhage | 0.82491661 |
| 102 | MP0001764_abnormal_homeostasis | 0.81941386 |
| 103 | MP0000858_altered_metastatic_potential | 0.80143941 |
| 104 | MP0008260_abnormal_autophagy | 0.79746823 |
| 105 | MP0008775_abnormal_heart_ventricle | 0.79565415 |
| 106 | MP0001915_intracranial_hemorrhage | 0.79564359 |
| 107 | MP0002132_abnormal_respiratory_system | 0.79380280 |
| 108 | MP0002972_abnormal_cardiac_muscle | 0.78859522 |
| 109 | MP0010234_abnormal_vibrissa_follicle | 0.78771755 |
| 110 | MP0000703_abnormal_thymus_morphology | 0.78670980 |
| 111 | MP0005166_decreased_susceptibility_to | 0.77609582 |
| 112 | MP0001216_abnormal_epidermal_layer | 0.75393895 |
| 113 | MP0000343_altered_response_to | 0.75260801 |
| 114 | MP0000350_abnormal_cell_proliferation | 0.75258989 |
| 115 | MP0005165_increased_susceptibility_to | 0.74791797 |
| 116 | MP0001697_abnormal_embryo_size | 0.74548062 |
| 117 | MP0003763_abnormal_thymus_physiology | 0.74239931 |
| 118 | MP0009763_increased_sensitivity_to | 0.74182848 |
| 119 | MP0000249_abnormal_blood_vessel | 0.74099773 |
| 120 | MP0002420_abnormal_adaptive_immunity | 0.73544461 |
| 121 | MP0002429_abnormal_blood_cell | 0.73077857 |
| 122 | MP0005164_abnormal_response_to | 0.72786667 |
| 123 | MP0005384_cellular_phenotype | 0.72786517 |
| 124 | MP0000716_abnormal_immune_system | 0.72547251 |
| 125 | MP0003795_abnormal_bone_structure | 0.72182362 |
| 126 | MP0001533_abnormal_skeleton_physiology | 0.71867062 |
| 127 | MP0003890_abnormal_embryonic-extraembry | 0.70961712 |
| 128 | MP0003186_abnormal_redox_activity | 0.70865622 |
| 129 | MP0003566_abnormal_cell_adhesion | 0.70830702 |
| 130 | MP0004947_skin_inflammation | 0.70349611 |
| 131 | MP0002295_abnormal_pulmonary_circulatio | 0.69596986 |
| 132 | MP0002078_abnormal_glucose_homeostasis | 0.68561858 |
| 133 | MP0002254_reproductive_system_inflammat | 0.67767634 |
| 134 | MP0008469_abnormal_protein_level | 0.67161174 |
| 135 | MP0000767_abnormal_smooth_muscle | 0.66414354 |
| 136 | MP0000427_abnormal_hair_cycle | 0.66076406 |
| 137 | MP0003943_abnormal_hepatobiliary_system | 0.65157193 |
| 138 | MP0001756_abnormal_urination | 0.62932806 |
| 139 | MP0003436_decreased_susceptibility_to | 0.62718027 |
| 140 | MP0002693_abnormal_pancreas_physiology | 0.61779174 |
| 141 | MP0009764_decreased_sensitivity_to | 0.61489654 |
| 142 | MP0005636_abnormal_mineral_homeostasis | 0.60934380 |
| 143 | MP0005376_homeostasis/metabolism_phenot | 0.59269933 |
| 144 | MP0002166_altered_tumor_susceptibility | 0.59145864 |
| 145 | MP0010678_abnormal_skin_adnexa | 0.58183787 |
| 146 | MP0009672_abnormal_birth_weight | 0.57432953 |
| 147 | MP0001873_stomach_inflammation | 0.56925334 |
| 148 | MP0004883_abnormal_blood_vessel | 0.56588324 |
| 149 | MP0003279_aneurysm | 0.55917542 |
| 150 | MP0005334_abnormal_fat_pad | 0.55160396 |
| 151 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54824011 |
| 152 | MP0002136_abnormal_kidney_physiology | 0.54369454 |
| 153 | MP0009642_abnormal_blood_homeostasis | 0.53850620 |
| 154 | MP0000163_abnormal_cartilage_morphology | 0.53429695 |
| 155 | MP0002098_abnormal_vibrissa_morphology | 0.53264268 |
| 156 | MP0001845_abnormal_inflammatory_respons | 0.52866455 |
| 157 | MP0001191_abnormal_skin_condition | 0.51471503 |
| 158 | MP0005647_abnormal_sex_gland | 0.51301871 |
| 159 | MP0002086_abnormal_extraembryonic_tissu | 0.50704025 |
| 160 | MP0000383_abnormal_hair_follicle | 0.50041248 |
| 161 | MP0000003_abnormal_adipose_tissue | 0.49927788 |
| 162 | MP0001661_extended_life_span | 0.48702962 |
| 163 | MP0004134_abnormal_chest_morphology | 0.48297299 |
| 164 | MP0004197_abnormal_fetal_growth/weight/ | 0.48059023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.74510377 |
| 2 | Papillary thyroid carcinoma (HP:0002895) | 5.13386028 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 5.02416039 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.93469924 |
| 5 | Abnormality of the common coagulation pathway (HP:0010990) | 4.78132674 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.72738999 |
| 7 | Xanthomatosis (HP:0000991) | 4.65732072 |
| 8 | Abnormality of the intrinsic pathway (HP:0010989) | 4.52756890 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.50996019 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.45569154 |
| 11 | Thyroid carcinoma (HP:0002890) | 4.01753006 |
| 12 | Fat malabsorption (HP:0002630) | 3.80905480 |
| 13 | Hypoglycemic coma (HP:0001325) | 3.76867828 |
| 14 | Conjugated hyperbilirubinemia (HP:0002908) | 3.74316975 |
| 15 | Hypolipoproteinemia (HP:0010981) | 3.63014410 |
| 16 | Complement deficiency (HP:0004431) | 3.54518171 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 3.46954145 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.46127328 |
| 19 | Hypochromic microcytic anemia (HP:0004840) | 3.45965505 |
| 20 | Tetraparesis (HP:0002273) | 3.42313709 |
| 21 | Curly hair (HP:0002212) | 3.41795710 |
| 22 | Epidermoid cyst (HP:0200040) | 3.41464142 |
| 23 | Hepatoblastoma (HP:0002884) | 3.27492116 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.13191972 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.12900375 |
| 26 | Abnormal foot bone ossification (HP:0010675) | 3.11168673 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.06647860 |
| 28 | Enlarged kidneys (HP:0000105) | 3.06519547 |
| 29 | Abnormal tarsal ossification (HP:0008369) | 3.01702262 |
| 30 | Acanthocytosis (HP:0001927) | 3.01453081 |
| 31 | Joint hemorrhage (HP:0005261) | 3.01377894 |
| 32 | Hyperglycemia (HP:0003074) | 2.92374557 |
| 33 | Menstrual irregularities (HP:0000858) | 2.88033343 |
| 34 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.86819320 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 2.85950599 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 2.85857095 |
| 37 | Short middle phalanx of the 5th finger (HP:0004220) | 2.85099503 |
| 38 | Hepatocellular carcinoma (HP:0001402) | 2.84973150 |
| 39 | Ankyloglossia (HP:0010296) | 2.83028444 |
| 40 | Hypoglycemic seizures (HP:0002173) | 2.76202485 |
| 41 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.75605395 |
| 42 | Hyperbilirubinemia (HP:0002904) | 2.71994161 |
| 43 | Myocardial infarction (HP:0001658) | 2.71601119 |
| 44 | Cupped ribs (HP:0000887) | 2.68268045 |
| 45 | Spondylolisthesis (HP:0003302) | 2.67245341 |
| 46 | Abnormality of complement system (HP:0005339) | 2.66324229 |
| 47 | Steatorrhea (HP:0002570) | 2.65867964 |
| 48 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.62434716 |
| 49 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.62434716 |
| 50 | Autoimmune hemolytic anemia (HP:0001890) | 2.62155773 |
| 51 | Abnormal pancreas size (HP:0012094) | 2.61307748 |
| 52 | Ketosis (HP:0001946) | 2.61071703 |
| 53 | Testicular neoplasm (HP:0010788) | 2.57824803 |
| 54 | Termporal pattern (HP:0011008) | 2.55353048 |
| 55 | Insidious onset (HP:0003587) | 2.55353048 |
| 56 | Thickened calvaria (HP:0002684) | 2.54305910 |
| 57 | Skin nodule (HP:0200036) | 2.53308200 |
| 58 | Cutaneous melanoma (HP:0012056) | 2.52954660 |
| 59 | Hyperammonemia (HP:0001987) | 2.49102389 |
| 60 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.47693430 |
| 61 | Abnormality of T cell number (HP:0011839) | 2.46858383 |
| 62 | Fatigue (HP:0012378) | 2.46671510 |
| 63 | Epiphyseal dysplasia (HP:0002656) | 2.43718585 |
| 64 | Vitreoretinal degeneration (HP:0000655) | 2.43330336 |
| 65 | Prolonged bleeding time (HP:0003010) | 2.39264976 |
| 66 | Acute myeloid leukemia (HP:0004808) | 2.36476094 |
| 67 | Increased mean platelet volume (HP:0011877) | 2.35550630 |
| 68 | Palpitations (HP:0001962) | 2.33781011 |
| 69 | Abnormality of the ischium (HP:0003174) | 2.31349928 |
| 70 | Thoracolumbar scoliosis (HP:0002944) | 2.30692058 |
| 71 | Ketoacidosis (HP:0001993) | 2.27265026 |
| 72 | Abnormality of oral frenula (HP:0000190) | 2.25126605 |
| 73 | Spinal cord lesions (HP:0100561) | 2.24560573 |
| 74 | Syringomyelia (HP:0003396) | 2.24560573 |
| 75 | T lymphocytopenia (HP:0005403) | 2.24468303 |
| 76 | Hypoplastic labia majora (HP:0000059) | 2.24201157 |
| 77 | Cavernous hemangioma (HP:0001048) | 2.20778625 |
| 78 | Poikilocytosis (HP:0004447) | 2.19203065 |
| 79 | Hypoplastic ischia (HP:0003175) | 2.18055661 |
| 80 | Papilledema (HP:0001085) | 2.16661013 |
| 81 | Thrombophlebitis (HP:0004418) | 2.15846221 |
| 82 | Hypercholesterolemia (HP:0003124) | 2.14034880 |
| 83 | Disinhibition (HP:0000734) | 2.13969344 |
| 84 | Biliary tract neoplasm (HP:0100574) | 2.12229875 |
| 85 | Menorrhagia (HP:0000132) | 2.11816106 |
| 86 | Deep philtrum (HP:0002002) | 2.11569201 |
| 87 | Unilateral renal agenesis (HP:0000122) | 2.10639380 |
| 88 | Abnormal platelet volume (HP:0011876) | 2.08788888 |
| 89 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.08578140 |
| 90 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.08235424 |
| 91 | Esophageal varix (HP:0002040) | 2.07595596 |
| 92 | Neoplasm of the small intestine (HP:0100833) | 2.06849565 |
| 93 | Epistaxis (HP:0000421) | 2.06803683 |
| 94 | Freckling (HP:0001480) | 2.04364659 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 2.04097539 |
| 96 | Neoplasm of the thyroid gland (HP:0100031) | 2.02682923 |
| 97 | Subaortic stenosis (HP:0001682) | 2.01947640 |
| 98 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.01947640 |
| 99 | Osteolytic defects of the hand bones (HP:0009699) | 2.01922288 |
| 100 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01922288 |
| 101 | Hyperglycinemia (HP:0002154) | 2.01922093 |
| 102 | Absent frontal sinuses (HP:0002688) | 2.00906321 |
| 103 | Abnormal cartilage morphology (HP:0002763) | 2.00023003 |
| 104 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99100292 |
| 105 | Arterial tortuosity (HP:0005116) | 1.99003907 |
| 106 | Protuberant abdomen (HP:0001538) | 1.98760512 |
| 107 | Beaking of vertebral bodies (HP:0004568) | 1.97428953 |
| 108 | Pancreatitis (HP:0001733) | 1.97399293 |
| 109 | Gingival bleeding (HP:0000225) | 1.96736718 |
| 110 | Premature rupture of membranes (HP:0001788) | 1.96603702 |
| 111 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.96584385 |
| 112 | Pheochromocytoma (HP:0002666) | 1.96566560 |
| 113 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.96392617 |
| 114 | Abnormality of the labia majora (HP:0012881) | 1.94566561 |
| 115 | Alveolar cell carcinoma (HP:0006519) | 1.94018832 |
| 116 | Exocrine pancreatic insufficiency (HP:0001738) | 1.93797116 |
| 117 | Pulmonary embolism (HP:0002204) | 1.93657950 |
| 118 | Central scotoma (HP:0000603) | 1.93354949 |
| 119 | Neonatal respiratory distress (HP:0002643) | 1.93346640 |
| 120 | Mitral stenosis (HP:0001718) | 1.93241660 |
| 121 | Symptomatic seizures (HP:0011145) | 1.93045316 |
| 122 | Abnormality of glycine metabolism (HP:0010895) | 1.92569078 |
| 123 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.92569078 |
| 124 | Spontaneous abortion (HP:0005268) | 1.92473886 |
| 125 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.90771140 |
| 126 | Abnormality of proline metabolism (HP:0010907) | 1.90539339 |
| 127 | Hydroxyprolinuria (HP:0003080) | 1.90539339 |
| 128 | Acute hepatic failure (HP:0006554) | 1.89914544 |
| 129 | Bladder carcinoma (HP:0002862) | 1.89759696 |
| 130 | Bladder neoplasm (HP:0009725) | 1.89759696 |
| 131 | Dyschromatopsia (HP:0007641) | 1.89305995 |
| 132 | Submucous cleft hard palate (HP:0000176) | 1.88873319 |
| 133 | Abnormal gallbladder morphology (HP:0012437) | 1.88838582 |
| 134 | Neoplasm of the liver (HP:0002896) | 1.87879484 |
| 135 | Polycythemia (HP:0001901) | 1.87755968 |
| 136 | Relative macrocephaly (HP:0004482) | 1.87697184 |
| 137 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.86274079 |
| 138 | Cardiovascular calcification (HP:0011915) | 1.86021288 |
| 139 | Abnormality of nucleobase metabolism (HP:0010932) | 1.85157426 |
| 140 | Aortic aneurysm (HP:0004942) | 1.84655609 |
| 141 | Gonadal dysgenesis (HP:0000133) | 1.81893027 |
| 142 | Cystic hygroma (HP:0000476) | 1.81802877 |
| 143 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.81633707 |
| 144 | Gout (HP:0001997) | 1.81539374 |
| 145 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.80856426 |
| 146 | Abnormality of alanine metabolism (HP:0010916) | 1.80856426 |
| 147 | Hyperalaninemia (HP:0003348) | 1.80856426 |
| 148 | Gonadotropin excess (HP:0000837) | 1.80053927 |
| 149 | Barrel-shaped chest (HP:0001552) | 1.78862878 |
| 150 | Hyperglycinuria (HP:0003108) | 1.78796470 |
| 151 | Vascular calcification (HP:0004934) | 1.78705478 |
| 152 | Eczematoid dermatitis (HP:0000976) | 1.78497215 |
| 153 | Vascular tortuosity (HP:0004948) | 1.77402580 |
| 154 | Neoplasm of the rectum (HP:0100743) | 1.76533010 |
| 155 | Abnormality of T cell physiology (HP:0011840) | 1.75849118 |
| 156 | Osteomyelitis (HP:0002754) | 1.75693636 |
| 157 | Decreased skull ossification (HP:0004331) | 1.75607256 |
| 158 | Aortic dissection (HP:0002647) | 1.75599403 |
| 159 | Right ventricular cardiomyopathy (HP:0011663) | 1.75521804 |
| 160 | Joint swelling (HP:0001386) | 1.74645608 |
| 161 | Metaphyseal cupping (HP:0003021) | 1.74628205 |
| 162 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.74115969 |
| 163 | Recurrent viral infections (HP:0004429) | 1.73045383 |
| 164 | Conjunctival telangiectasia (HP:0000524) | 1.72683287 |
| 165 | Generalized aminoaciduria (HP:0002909) | 1.72380897 |
| 166 | Subacute progressive viral hepatitis (HP:0006572) | 1.71524991 |
| 167 | Hematochezia (HP:0002573) | 1.70635481 |
| 168 | Stomatitis (HP:0010280) | 1.70383550 |
| 169 | Abdominal distention (HP:0003270) | 1.69817115 |
| 170 | Metabolic acidosis (HP:0001942) | 1.69276271 |
| 171 | Malnutrition (HP:0004395) | 1.69224926 |
| 172 | Spontaneous hematomas (HP:0007420) | 1.69143945 |
| 173 | Nonimmune hydrops fetalis (HP:0001790) | 1.68290179 |
| 174 | Conjunctival hamartoma (HP:0100780) | 1.65306600 |
| 175 | Metaphyseal dysplasia (HP:0100255) | 1.64852792 |
| 176 | Abnormal biliary tract morphology (HP:0012440) | 1.64631181 |
| 177 | Diastasis recti (HP:0001540) | 1.64603238 |
| 178 | Mucosal telangiectasiae (HP:0100579) | 1.63282845 |
| 179 | Irregular vertebral endplates (HP:0003301) | 1.62584804 |
| 180 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.62271178 |
| 181 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.62258930 |
| 182 | Small epiphyses (HP:0010585) | 1.62245529 |
| 183 | Ectopia lentis (HP:0001083) | 1.61641695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.72178071 |
| 2 | BMPR2 | 2.95854875 |
| 3 | ERN1 | 2.86727239 |
| 4 | TAOK3 | 2.46947949 |
| 5 | FGFR4 | 2.46842532 |
| 6 | FGFR2 | 2.43359858 |
| 7 | TRIM28 | 2.20372447 |
| 8 | SIK3 | 2.10603610 |
| 9 | PDK2 | 2.10378227 |
| 10 | LATS1 | 1.99707167 |
| 11 | AKT3 | 1.98246962 |
| 12 | EPHB1 | 1.97605589 |
| 13 | MAP3K3 | 1.94281521 |
| 14 | NUAK1 | 1.91026622 |
| 15 | PIK3CG | 1.90617955 |
| 16 | BRSK2 | 1.89929654 |
| 17 | INSRR | 1.87506667 |
| 18 | CDK12 | 1.85103498 |
| 19 | EPHA3 | 1.83213138 |
| 20 | STK10 | 1.82514772 |
| 21 | ACVR1B | 1.69999568 |
| 22 | EIF2AK3 | 1.66279683 |
| 23 | SRPK1 | 1.65100466 |
| 24 | TYK2 | 1.64504253 |
| 25 | TNIK | 1.64289825 |
| 26 | RIPK4 | 1.60013794 |
| 27 | PTK6 | 1.56822846 |
| 28 | BRD4 | 1.56534779 |
| 29 | MAP3K14 | 1.55136209 |
| 30 | TGFBR2 | 1.54984956 |
| 31 | MET | 1.52988426 |
| 32 | BCR | 1.49812553 |
| 33 | STK3 | 1.49284325 |
| 34 | ERBB4 | 1.46976636 |
| 35 | ITK | 1.46809970 |
| 36 | PDGFRA | 1.39564250 |
| 37 | SIK1 | 1.38378419 |
| 38 | MAP3K12 | 1.37478346 |
| 39 | FLT3 | 1.35945228 |
| 40 | MAP3K10 | 1.35763564 |
| 41 | BCKDK | 1.34001957 |
| 42 | STK24 | 1.31180374 |
| 43 | FGFR3 | 1.29115304 |
| 44 | EPHA2 | 1.27658471 |
| 45 | BMPR1B | 1.22488955 |
| 46 | MAPK15 | 1.18713256 |
| 47 | MYLK | 1.18233323 |
| 48 | SCYL2 | 1.16826144 |
| 49 | KDR | 1.16606021 |
| 50 | STK38L | 1.16440622 |
| 51 | KSR1 | 1.13551663 |
| 52 | MST4 | 1.11137167 |
| 53 | GSK3A | 1.09371643 |
| 54 | YES1 | 1.08052331 |
| 55 | MAP3K5 | 1.06909104 |
| 56 | TTK | 1.05281604 |
| 57 | CHUK | 1.01279994 |
| 58 | MAP3K6 | 1.01169982 |
| 59 | PDGFRB | 0.97975858 |
| 60 | STK39 | 0.97525397 |
| 61 | ERBB3 | 0.92868046 |
| 62 | MELK | 0.92555676 |
| 63 | VRK1 | 0.92036807 |
| 64 | PTK2 | 0.91686726 |
| 65 | PLK3 | 0.88443987 |
| 66 | CSK | 0.87363507 |
| 67 | NEK1 | 0.85938891 |
| 68 | PASK | 0.85315524 |
| 69 | CSNK1A1L | 0.84840516 |
| 70 | DYRK3 | 0.84599952 |
| 71 | CSNK1G1 | 0.84439231 |
| 72 | DYRK1B | 0.83474444 |
| 73 | RPS6KA5 | 0.82908354 |
| 74 | HIPK2 | 0.82134667 |
| 75 | JAK1 | 0.81513272 |
| 76 | LMTK2 | 0.81419405 |
| 77 | CDC7 | 0.81350530 |
| 78 | FER | 0.80631461 |
| 79 | BRAF | 0.80134916 |
| 80 | TBK1 | 0.79137662 |
| 81 | TRPM7 | 0.78845859 |
| 82 | WNK4 | 0.77902368 |
| 83 | CSF1R | 0.77821079 |
| 84 | NEK9 | 0.77089331 |
| 85 | EIF2AK1 | 0.74849773 |
| 86 | PAK3 | 0.74318481 |
| 87 | RPS6KA4 | 0.73898774 |
| 88 | PLK2 | 0.73895299 |
| 89 | MAP3K2 | 0.72110842 |
| 90 | MAP2K3 | 0.71260167 |
| 91 | NLK | 0.71211057 |
| 92 | JAK2 | 0.70183487 |
| 93 | MARK3 | 0.69834910 |
| 94 | CAMKK2 | 0.68408032 |
| 95 | CLK1 | 0.68072372 |
| 96 | MST1R | 0.67895878 |
| 97 | MKNK1 | 0.67467183 |
| 98 | FGFR1 | 0.66551599 |
| 99 | TEC | 0.66280137 |
| 100 | GRK6 | 0.65584920 |
| 101 | PAK2 | 0.64773696 |
| 102 | PKN1 | 0.64762158 |
| 103 | PRKAA2 | 0.64157650 |
| 104 | PRKCQ | 0.60615241 |
| 105 | IRAK3 | 0.60243997 |
| 106 | MTOR | 0.59826197 |
| 107 | CDK6 | 0.59821977 |
| 108 | DDR2 | 0.59648882 |
| 109 | STK4 | 0.59368914 |
| 110 | JAK3 | 0.58122278 |
| 111 | MAPK7 | 0.57427553 |
| 112 | IKBKB | 0.55993530 |
| 113 | RAF1 | 0.55880850 |
| 114 | IKBKE | 0.54649888 |
| 115 | TSSK6 | 0.53298866 |
| 116 | PBK | 0.53268890 |
| 117 | CSNK1G3 | 0.52992259 |
| 118 | OBSCN | 0.52485976 |
| 119 | EIF2AK2 | 0.52360743 |
| 120 | CDK9 | 0.50337312 |
| 121 | NEK6 | 0.49805902 |
| 122 | MKNK2 | 0.49534595 |
| 123 | SGK2 | 0.49351380 |
| 124 | MAPKAPK2 | 0.48003601 |
| 125 | SGK3 | 0.47206614 |
| 126 | IRAK1 | 0.46321435 |
| 127 | ZAK | 0.45838457 |
| 128 | TXK | 0.44736661 |
| 129 | HCK | 0.44396731 |
| 130 | BRSK1 | 0.43906962 |
| 131 | ALK | 0.42688360 |
| 132 | MAP3K4 | 0.41079849 |
| 133 | PIK3CA | 0.40686152 |
| 134 | RIPK1 | 0.40652125 |
| 135 | TGFBR1 | 0.40297735 |
| 136 | RET | 0.39442942 |
| 137 | MAPK4 | 0.39241033 |
| 138 | DMPK | 0.38794411 |
| 139 | EGFR | 0.38745103 |
| 140 | PRKG2 | 0.38707209 |
| 141 | MAP2K2 | 0.38223664 |
| 142 | PIM1 | 0.38019561 |
| 143 | IRAK4 | 0.37959930 |
| 144 | ABL1 | 0.37137686 |
| 145 | WEE1 | 0.37096544 |
| 146 | ATM | 0.34965187 |
| 147 | CCNB1 | 0.34758737 |
| 148 | KSR2 | 0.33660985 |
| 149 | AKT2 | 0.30578068 |
| 150 | GRK7 | 0.29564793 |
| 151 | PRKCE | 0.29372068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.90765663 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.00196990 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.99040628 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.70762780 |
| 5 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.54454310 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.47984934 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.46387106 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.46015819 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.32771590 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.23302828 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16429614 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.08236416 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.07919101 |
| 14 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.02045016 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.01679064 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.01488072 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97806101 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.97209025 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.92693577 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92414860 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.91949100 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.85549740 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.82731889 |
| 24 | Shigellosis_Homo sapiens_hsa05131 | 1.67713316 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.66816718 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.66746718 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.66491216 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.60544844 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60312359 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.59372152 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57551702 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56907332 |
| 33 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.56418690 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.55592314 |
| 35 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.54416757 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51750373 |
| 37 | Thyroid cancer_Homo sapiens_hsa05216 | 1.50258178 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.49525452 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.48509171 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.46017340 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45185117 |
| 42 | Measles_Homo sapiens_hsa05162 | 1.43807889 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.43789789 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.41096733 |
| 45 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.39671048 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38286821 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.38029955 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 1.35193429 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.34902028 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.31535796 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.29777783 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.28946120 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28141683 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.28114508 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25353078 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.22580001 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.20054784 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 1.19426691 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.17823674 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.16949478 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15633363 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14602619 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13227547 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12889711 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.12497444 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11856735 |
| 67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.11118658 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 1.10218163 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 1.09836171 |
| 70 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.09297932 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.08929097 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07185210 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 1.06949645 |
| 74 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.06949613 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06884726 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.06004204 |
| 77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.05485664 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.04708246 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 1.00152968 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.00136845 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.99438685 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96944127 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96872620 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95944214 |
| 85 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.94778425 |
| 86 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94724483 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94231740 |
| 88 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.91884129 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91776992 |
| 90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.90609300 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90496065 |
| 92 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90263874 |
| 93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87141654 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85539744 |
| 95 | Apoptosis_Homo sapiens_hsa04210 | 0.82099232 |
| 96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82086198 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.80100615 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79188644 |
| 99 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78532398 |
| 100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.77396781 |
| 101 | Leishmaniasis_Homo sapiens_hsa05140 | 0.77286413 |
| 102 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.75933558 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74096322 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.72073346 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70826536 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70818479 |
| 107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69396641 |
| 108 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68343859 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67791729 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67768344 |
| 111 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67732582 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67196976 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66893293 |
| 114 | Tuberculosis_Homo sapiens_hsa05152 | 0.66042375 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65415223 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64887673 |
| 117 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.64830266 |
| 118 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.63635909 |
| 119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62034758 |
| 120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61533536 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58778954 |
| 122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.58316067 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.57678259 |
| 124 | RNA degradation_Homo sapiens_hsa03018 | 0.57517474 |
| 125 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.57201437 |
| 126 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.55423789 |
| 127 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54058373 |
| 128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49455633 |
| 129 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49329892 |
| 130 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49091763 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47887172 |
| 132 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47108591 |
| 133 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46336922 |
| 134 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.46054931 |
| 135 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45833629 |
| 136 | Melanoma_Homo sapiens_hsa05218 | 0.45520746 |
| 137 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44897466 |
| 138 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41780848 |
| 139 | Prostate cancer_Homo sapiens_hsa05215 | 0.40616923 |
| 140 | Adherens junction_Homo sapiens_hsa04520 | 0.39987987 |
| 141 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39411127 |
| 142 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37194230 |
| 143 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34725811 |
| 144 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34359025 |
| 145 | Prion diseases_Homo sapiens_hsa05020 | 0.31474144 |
| 146 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.30764235 |
| 147 | Focal adhesion_Homo sapiens_hsa04510 | 0.29887570 |
| 148 | Legionellosis_Homo sapiens_hsa05134 | 0.29385515 |
| 149 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.27228486 |
| 150 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25516285 |
| 151 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.24559904 |
| 152 | Amoebiasis_Homo sapiens_hsa05146 | 0.23428328 |
| 153 | Malaria_Homo sapiens_hsa05144 | 0.22649576 |
| 154 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.22007162 |
| 155 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.20988175 |
| 156 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.20703960 |
| 157 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.19911950 |
| 158 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.19517066 |
| 159 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.18313660 |
| 160 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.17775983 |
| 161 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.17575552 |
| 162 | Circadian rhythm_Homo sapiens_hsa04710 | 0.17021936 |
| 163 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.16714351 |
| 164 | Hepatitis C_Homo sapiens_hsa05160 | 0.14464453 |
| 165 | Bladder cancer_Homo sapiens_hsa05219 | 0.13978498 |
| 166 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11972679 |
| 167 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.11350060 |

